Protagenic Therapeutics (PTIX) — Financial Flexibility Index
Protagenic Therapeutics (PTIX) has a Financial Flexibility Index of -0.06x as of December 2025. Free cash flow of $-410.42K (operating CF $-410.42K minus capex $6.00) represents 0% of total liabilities ($6.82 Million). Check PTIX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Protagenic Therapeutics Financial Flexibility Index (1995–2025)
Historical Financial Flexibility Index trend for Protagenic Therapeutics across 31 annual periods. See PTIX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Protagenic Therapeutics (1995–2025)
Year-by-year free cash flow to debt coverage for Protagenic Therapeutics. For the full company profile including market capitalisation, see PTIX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.61x | $-4.14 Million | $-4.14 Million | $6.82 Million | ▲ +86.4% |
| 2024 | -4.47x | $-4.22 Million | $-4.22 Million | $942.76K | ▲ +17.5% |
| 2023 | -5.42x | $-3.55 Million | $-3.70 Million | $655.25K | ▼ -204.9% |
| 2022 | -1.78x | $-1.99 Million | $-1.99 Million | $1.12 Million | ▲ +28.9% |
| 2021 | -2.50x | $-2.80 Million | $-2.80 Million | $1.12 Million | ▼ -276.6% |
| 2020 | -0.66x | $-1.35 Million | $-1.35 Million | $2.03 Million | ▼ -101.2% |
| 2019 | -0.33x | $-487.99K | $-487.99K | $1.48 Million | ▲ +72.0% |
| 2018 | -1.18x | $-1.07 Million | $-1.07 Million | $907.77K | ▲ +52.0% |
| 2017 | -2.46x | $-1.38 Million | $-1.38 Million | $561.69K | ▼ -47.6% |
| 2016 | -1.67x | $-1.14 Million | $-1.14 Million | $684.86K | ▼ -210.9% |
| 2015 | -0.54x | $-377.00K | $-378.00K | $704.00K | ▲ +10.5% |
| 2015 | -0.60x | $-377.00K | $-378.00K | $630.00K | ▲ +76.0% |
| 2014 | -2.50x | $-789.00K | $-790.00K | $316.00K | ▲ +0.0% |
| 2013 | -2.50x | $-789.00K | $-790.00K | $316.00K | ▼ -13910.0% |
| 2012 | -0.02x | $-324.00K | $-324.00K | $18.18 Million | ▲ +98.2% |
| 2010 | -1.00x | $-11.21 Million | $-11.25 Million | $11.17 Million | ▼ -728.0% |
| 2009 | -0.12x | $-2.33 Million | $-3.02 Million | $19.25 Million | ▼ -145.8% |
| 2008 | 0.26x | $6.38 Million | $4.36 Million | $24.11 Million | ▲ +138.0% |
| 2007 | -0.70x | $-4.94 Million | $-5.21 Million | $7.10 Million | ▼ -395.1% |
| 2006 | 0.24x | $1.01 Million | $931.00K | $4.27 Million | ▲ +150.7% |
| 2005 | -0.47x | $-44.00K | $-44.00K | $94.47K | ▼ -133.2% |
| 2004 | -0.20x | $-842.00K | $-842.00K | $4.21 Million | ▼ -152.2% |
| 2003 | 0.38x | $3.35 Million | $1.87 Million | $8.76 Million | ▼ -19.8% |
| 2002 | 0.48x | $4.13 Million | $2.35 Million | $8.65 Million | ▼ -12.5% |
| 2001 | 0.55x | $5.29 Million | $1.50 Million | $9.71 Million | ▼ -26.7% |
| 2000 | 0.74x | $6.74 Million | $3.51 Million | $9.06 Million | ▲ +1643.2% |
| 1999 | 0.04x | $412.00K | $331.00K | $9.66 Million | ▲ +187.0% |
| 1998 | -0.05x | $-369.00K | $-434.00K | $7.53 Million | ▼ -118.4% |
| 1997 | 0.27x | $657.00K | $-2.20 Million | $2.47 Million | ▲ +23.6% |
| 1996 | 0.22x | $1.19 Million | $-230.00K | $5.53 Million | ▲ +5.2% |
| 1995 | 0.20x | $730.00K | $-600.00K | $3.57 Million | — |